Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid

Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Thyroid Cancer Endocrine Gland Neoplasms Endocrine System Diseases Head and Neck Neoplasms Lymph Node Metastases Lymphatic Metastasis Neoplasm Metastasis Neoplasms Neoplasms by Site Neoplastic Processes Pathologic Processes Pathological Conditions, Signs and Symptoms Thyroid Diseases Thyroid Neoplasms

Sex eligibility

All sexes

Study type

Observational

Primary location

AOU Cagliari

Cagliari, CA, 09100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with papillary microcarcinoma of the thyroid

Exclusion criteria

Patients with thyroid nodules > 1 cm; incomplete data

Treatment and study plan

Thyroidecomt and lymphectomy

Procedure

Patients underwent total thyroidectomy or lobectomy associated to lymph node sampling or neck lymphectomy

Primary outcomes

Incidence of lymph node metastasis

Time frame: 1 year

To define the incidence of lymph node metastasis in patients with papillary microcarcinoma

Secondary outcomes

Predicrive factors of lymph node metastasis

Time frame: 1 year

To assesss predictive factors of lymph node metastasis

Sponsors and collaborators

Lead sponsor

University of Cagliari

Other

Registry information

Important dates

Study start: 2010
Primary completion: 2018
Study completion: 2020
First posted: Feb 18, 2020
Registry last updated: Feb 18, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed